Want to create an interactive transcript for this episode?
Podcast: ResusX:Podcast
Episode: Efficacy and safety of corticosteroids in critically ill patients: a systematic review and meta-analysis
Description: When someone is critically ill, whether battling sepsis, ARDS, or severe pneumonia, corticosteroids have long been a debated topic. A massive new meta-analysis pooling data from over 10,000 ICU patients finally brings clarity. The headline: early, low-dose, prolonged steroid therapy cuts short-term mortality by roughly 15%, slashes ICU stays by 2 days, reduces time on ventilators by over 4 days, and boosts ventilator-free days—all without increasing infection or bleeding risks. Sure, there’s a slight uptick in hyperglycemia, but that’s a small price for improved survival and recoveryÂ
What does this mean for frontline clinicians? Think “early, gentle, and sustained...